Evidence map›Paper›PMID 33441630›Full record

ArticleScientific reports2021

CD206+ macrophage is an accelerator of endometriotic-like lesion via promoting angiogenesis in the endometriosis mouse model.

Yosuke Ono, Osamu Yoshino, Takehiro Hiraoka, Erina Sato, Akiko Furue, Allah Nawaz, Hideki Hatta, Yoshiyuki Fukushi, Shinichiro Wada, Kazuyuki Tobe and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Exploring macrophage and nerve interaction in endometriosis-associated pain: the inductive role of IL-33.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Yosuke OnoDepartment of Obstetrics and Gynecology, Teine Keijinkai Hospital, Sapporo, Japan.
Osamu YoshinoDepartment of Obstetrics and Gynecology, Kitasato University School of Medicine, Sagamihara, Japan. oyoshino624@gmail.com.
Takehiro HiraokaDepartment of Obstetrics and Gynecology, Kitasato University School of Medicine, Sagamihara, Japan.
Erina SatoDepartment of Obstetrics and Gynecology, Kitasato University School of Medicine, Sagamihara, Japan.
Akiko FurueDepartment of Obstetrics and Gynecology, Kitasato University School of Medicine, Sagamihara, Japan.
Allah NawazDepartment of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, Toyama, Japan.
Hideki HattaDepartment of Diagnostic Pathology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Yoshiyuki FukushiDepartment of Obstetrics and Gynecology, Teine Keijinkai Hospital, Sapporo, Japan.
Shinichiro WadaDepartment of Obstetrics and Gynecology, Teine Keijinkai Hospital, Sapporo, Japan.
Kazuyuki TobeFirst Department of Internal Medicine, University of Toyama, Toyama, Japan.
Yasushi HirotaDepartment of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
Yutaka OsugaDepartment of Obstetrics and Gynecology, The University of Tokyo, Tokyo, Japan.
Nobuya UnnoDepartment of Obstetrics and Gynecology, Kitasato University School of Medicine, Sagamihara, Japan.
Shigeru SaitoDepartment of Obstetrics and Gynecology, University of Toyama, Toyama, Japan. s30saito@med.u-toyama.ac.jp.
Kitasato University · JPUniversity of Toyama · JPTeine Keijinkai Hospital · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In endometriosis, M2 MΦs are dominant in endometriotic lesions, but the actual role of M2 MΦ is unclear. CD206 positive (+) MΦ is classified in one of M2 type MΦs and are known to produce cytokines and chemokines. In the present study, we used CD206 diphtheria toxin receptor mice, which enable to deplete CD206+ cells with diphtheria toxin (DT) in an endometriosis mouse model. The depletion of CD206+ MΦ decreased the total weight of endometriotic-like lesions significantly (p < 0.05). In the endometriotic-like lesions in the DT group, a lower proliferation of endometriotic cells and the decrease of angiogenesis were observed. In the lesions, the mRNA levels of VEGFA and TGFβ1, angiogenic factors, in the DT group significantly decreased to approximately 50% and 30% of control, respectively. Immunohistochemical study revealed the expressions of VEGFA and an endothelial cell marker CD31 in lesions of the DT group, were dim compared to those in control. Also, the number of TGFβ1 expressing MΦ was significantly reduced compared to control. These data suggest that CD206+ MΦ promotes the formation of endometriotic-like lesions by inducing angiogenesis around the lesions.

Indexed as

Angiogenesis Inducing AgentsAnimalsCell ProliferationCytokinesDisease Models, AnimalEndometriosisFemaleHeparin-binding EGF-like Growth FactorLectins, C-TypeMacrophagesMannose-Binding LectinsMannose ReceptorMiceMice, TransgenicNeovascularization, PathologicReceptors, Cell SurfaceAngiogenesis Inducing AgentsCytokinesHeparin-binding EGF-like Growth FactorLectins, C-TypeMannose-Binding LectinsMannose ReceptorReceptors, Cell SurfaceTransforming Growth Factor beta1Vascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID33441630
PMCPMC7807007
OpenAlexW3119738856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.